---
title: "Report: Novartis and Roche are about to reach a drug pricing agreement in the United States, easing trade tensions in Switzerland"
description: "According to informed sources, the White House is expected to announce as early as Friday a drug pricing agreement with pharmaceutical giants Novartis and Roche, a move that will further ease trade te"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/270049919.md"
published_at: "2025-12-17T18:18:40.000Z"
---

# Report: Novartis and Roche are about to reach a drug pricing agreement in the United States, easing trade tensions in Switzerland

> According to informed sources, the White House is expected to announce as early as Friday a drug pricing agreement with pharmaceutical giants Novartis and Roche, a move that will further ease trade tensions with Switzerland. Other pharmaceutical companies may also appear on the announcement list; in recent months, companies such as Pfizer and AstraZeneca have signed similar agreements. As part of efforts to lower drug prices in the United States, these companies have agreed to cut costs in exchange for tariff exemptions and potential regulatory relief. (Bloomberg)

According to informed sources, the White House is expected to announce a drug pricing agreement with pharmaceutical giants Novartis and Roche as early as Friday, a move that will further ease trade tensions with Switzerland. Other pharmaceutical companies may also appear on the announcement list; in recent months, companies such as Pfizer and AstraZeneca have signed similar agreements. As part of efforts to lower drug prices in the United States, these companies have agreed to cut costs in exchange for tariff exemptions and potential regulatory relief. (Bloomberg)

### Related Stocks

- [RHHBY.US - Roche](https://longbridge.com/en/quote/RHHBY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Rovi jumps after announcing drug deal with Roche | Shares in Rovi rose about 8% following the announcement of a drug manufacturing deal with Roche. The agreement is expect | [Link](https://longbridge.com/en/news/262092937.md) |
| Obesity challenger Roche 'only scratching surface' of market potential, says CEO | Roche's CEO, Thomas Schinecker, expressed confidence in the growth potential of the weight-loss drug market, stating the | [Link](https://longbridge.com/en/news/262356985.md) |
| CICC Reaffirms Their Buy Rating on NIO Inc. Class A (9866) | CICC analyst maintained a Buy rating on NIO Inc. Class A yesterday and set a price target of HK$50.00.Valentine's Day Sa | [Link](https://longbridge.com/en/news/275967598.md) |
| Olympics-Ice hockey-Durante dazzles despite Italy exit to US | Italy's goalie Gabriella Durante delivered an outstanding performance despite Italy's exit from the women's Olympic ice  | [Link](https://longbridge.com/en/news/275954373.md) |
| Lowe's Spokesperson Says Co To Cut About 600 Corporate & Support Roles | Lowe's Companies Inc :LOWE'S COMPANIES : TO REDUCE APPROXIMATELY 600 CORPORATE AND SUPPORT ROLES, LESS THAN 1 PERCENT OF | [Link](https://longbridge.com/en/news/275953193.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.